Literature DB >> 28660499

Good Intentions, But What About Unintended Consequences?

Helen C Kales1,2,3, Donovan T Maust4,5.   

Abstract

Mesh:

Year:  2017        PMID: 28660499     DOI: 10.1007/s40264-017-0554-x

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


× No keyword cloud information.
  13 in total

1.  Outcomes of antipsychotic drug use in community-dwelling elders with dementia.

Authors:  Ann Kolanowski; Donna Fick; Jennifer L Waller; Frank Ahern
Journal:  Arch Psychiatr Nurs       Date:  2006-10       Impact factor: 2.218

2.  Response to regulatory stringency: the case of antipsychotic medication use in nursing homes.

Authors:  John R Bowblis; Stephen Crystal; Orna Intrator; Judith A Lucas
Journal:  Health Econ       Date:  2011-09-01       Impact factor: 3.046

Review 3.  Management of neuropsychiatric symptoms of dementia in clinical settings: recommendations from a multidisciplinary expert panel.

Authors:  Helen C Kales; Laura N Gitlin; Constantine G Lyketsos
Journal:  J Am Geriatr Soc       Date:  2014-03-17       Impact factor: 5.562

4.  Antipsychotics, other psychotropics, and the risk of death in patients with dementia: number needed to harm.

Authors:  Donovan T Maust; Hyungjin Myra Kim; Lisa S Seyfried; Claire Chiang; Janet Kavanagh; Lon S Schneider; Helen C Kales
Journal:  JAMA Psychiatry       Date:  2015-05       Impact factor: 21.596

5.  Risk of mortality among individual antipsychotics in patients with dementia.

Authors:  Helen C Kales; Hyungjin Myra Kim; Kara Zivin; Marcia Valenstein; Lisa S Seyfried; Claire Chiang; Francesca Cunningham; Lon S Schneider; Frederic C Blow
Journal:  Am J Psychiatry       Date:  2011-10-31       Impact factor: 18.112

Review 6.  Practical guidelines for the acute emergency sedation of the severely agitated older patient.

Authors:  C Peisah; D K Y Chan; R McKay; S E Kurrle; S G Reutens
Journal:  Intern Med J       Date:  2011-09       Impact factor: 2.048

Review 7.  Effect of selective serotonin reuptake inhibitors in Alzheimer's disease with comorbid depression: a meta-analysis of depression and cognitive outcomes.

Authors:  Amir A Sepehry; Philip E Lee; Ging Yuek R Hsiung; B Lynn Beattie; Claudia Jacova
Journal:  Drugs Aging       Date:  2012-10       Impact factor: 3.923

8.  Effect of citalopram on agitation in Alzheimer disease: the CitAD randomized clinical trial.

Authors:  Anton P Porsteinsson; Lea T Drye; Bruce G Pollock; D P Devanand; Constantine Frangakis; Zahinoor Ismail; Christopher Marano; Curtis L Meinert; Jacobo E Mintzer; Cynthia A Munro; Gregory Pelton; Peter V Rabins; Paul B Rosenberg; Lon S Schneider; David M Shade; Daniel Weintraub; Jerome Yesavage; Constantine G Lyketsos
Journal:  JAMA       Date:  2014-02-19       Impact factor: 56.272

9.  Trends in Psychotropic Dispensing Among Older Adults with Dementia Living in Long-Term Care Facilities: 2004-2013.

Authors:  Akshya Vasudev; Salimah Z Shariff; Kuan Liu; Amer M Burhan; Nathan Herrmann; Sean Leonard; Muhammad Mamdani
Journal:  Am J Geriatr Psychiatry       Date:  2015-07-17       Impact factor: 4.105

10.  Antipsychotic Prescribing to Patients Diagnosed with Dementia Without a Diagnosis of Psychosis in the Context of National Guidance and Drug Safety Warnings: Longitudinal Study in UK General Practice.

Authors:  S Jill Stocks; Evangelos Kontopantelis; Roger T Webb; Anthony J Avery; Alistair Burns; Darren M Ashcroft
Journal:  Drug Saf       Date:  2017-08       Impact factor: 5.606

View more
  1 in total

1.  Dementia-related neuropsychiatric symptoms: inequalities in pharmacological treatment and institutionalization.

Authors:  Javier Mar; Arantzazu Arrospide; Myriam Soto-Gordoa; Álvaro Iruin; Mikel Tainta; Andrea Gabilondo; Lore Mar-Barrutia; Montserrat Calvo; Maider Mateos; Oliver Ibarrondo
Journal:  Neuropsychiatr Dis Treat       Date:  2019-07-17       Impact factor: 2.570

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.